Showing 261 - 280 results of 1,143 for search '"kidney disease"', query time: 0.08s Refine Results
  1. 261
  2. 262

    Facilitating active participation in anticoagulant decisions in advanced kidney disease: co-production of a question prompt list by Kathrine Parker, Abigail Needham, Jecko Thachil, Sandip Mitra, Penny Lewis

    Published 2025-01-01
    “…Abstract Background People with chronic kidney disease are at increased risk of thrombotic and bleeding episodes making anticoagulant treatment decisions challenging. …”
    Get full text
    Article
  3. 263
  4. 264
  5. 265

    Construction and validation of a predictive model for the risk of osteoporosis in patients with chronic kidney disease based on NHANES data. by Chunjie She, Hefeng Liu

    Published 2025-01-01
    “…<h4>Background</h4>Chronic kidney disease (CKD) patients tend to exhibit a heightened susceptibility to osteoporosis owing to abnormalities in mineral and bone metabolism. …”
    Get full text
    Article
  6. 266
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272

    Preserved ratio impaired spirometry, airflow obstruction, and their trajectories in relationship to chronic kidney disease: a prospective cohort study by Ikramulhaq Patel, JingYan Zhang, YinHe Chai, YuShun Qiao, HongJian Gong, Hui Xu, JianBo Zhou

    Published 2025-01-01
    “…This study aimed to investigate the impact of baseline and trajectories of spirometry findings on future chronic kidney disease (CKD) events. This UK Biobank cohort study included participants with CKD who underwent spirometry at baseline (2006–2010). …”
    Get full text
    Article
  13. 273
  14. 274

    Matrix Gla Protein and Nitric Oxide Synthase-3 Genetic Variants in Chronic Kidney Disease and Their Relation with Cardiovascular Risk by G. Priyadarshini, Sreejith Parameswaran, Jayaprakash Sahoo, Sandhiya Selvarajan, Ananthakrishnan Ramesh, Medha Rajappa

    Published 2024-01-01
    “…Background. Chronic kidney disease (CKD) is defined by gradual deterioration of renal parenchyma and decline of functioning nephrons. …”
    Get full text
    Article
  15. 275
  16. 276

    Association of dietary niacin intake with all-cause mortality in chronic kidney disease: A retrospective cohort study of NHANES. by Meijuan Xiang, Jianyun Peng, Zhihong Gui, Ju Jin, Jinling Meng

    Published 2025-01-01
    “…<h4>Background</h4>Dietary niacin intake has a positive influence on several chronic diseases, while the impact of dietary niacin intake on prognosis in chronic kidney disease (CKD) remains unknown. The study would explore the association between dietary niacin intake and all-cause mortality in CKD patients.…”
    Get full text
    Article
  17. 277

    The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review. by Sarah Elshahat, Paul Cockwell, Alexander P Maxwell, Matthew Griffin, Timothy O'Brien, Ciaran O'Neill

    Published 2020-01-01
    “…Chronic kidney disease (CKD) affects over 10% of the global population and poses significant challenges for societies and health care systems worldwide. …”
    Get full text
    Article
  18. 278
  19. 279
  20. 280

    Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study by Avani D. Joshi, David A. Holdford, Donald F. Brophy, Spencer E. Harpe, Darcy Mays, Todd W. B. Gehr

    Published 2012-01-01
    “…Intravenous (IV) iron and Erythropoiesis Stimulating Agents (ESAs) are recommended for anemia management in chronic kidney disease (CKD). This retrospective cohort study analyzed utilization patterns of IV iron and ESA in patients over 18 years of age admitted to University Health System Hospitals with a primary or secondary diagnosis of CKD between January 1, 2006 to December 31, 2008. …”
    Get full text
    Article